Akso Health Group
Akso Health Group (AHG) Stock Overview
Explore Akso Health Group’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
32.9M
P/E Ratio
-2.49
EPS (TTM)
$-0.08
ROE
-0.13%
AHG Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Akso Health Group (AHG) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 61.87, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.53.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.49 and a market capitalization of 32.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Technical Indicators
Company Profile
Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, etc. It also offers consultancy and information technology support services; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Beijing, China. As of July 13, 2021, Akso Health Group operates as a subsidiary of Webao Limited.
Yilin Wang
9
Room 515, Qingdao
2017